Brain Amylin Signaling, Feeding, and Reward. [PDF]
Mietlicki-Baase EG.
europepmc +1 more source
Emerging pharmacological targets in migraine therapy: CGRP and beyond. [PDF]
Atraszkiewicz D, Dahiya D.
europepmc +1 more source
For Weight Loss: Why Do GLP-1 Agonists Work, and How Can We Make Them Work Better? [PDF]
Giang C +5 more
europepmc +1 more source
Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective. [PDF]
Ahmad I +9 more
europepmc +1 more source
Association Between Serum Amylin, Irisin, and Sirtuin 1 in Male Patients with Type 2 Diabetes and Diabetic Nephropathy. [PDF]
Sabih Wajdi S +4 more
europepmc +1 more source
New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus. [PDF]
Panou T +3 more
europepmc +1 more source
Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis. [PDF]
Kamrul-Hasan ABM +5 more
europepmc +1 more source
Combination Pharmacotherapies for Obesity-Current Evidence and Future Directions. [PDF]
Kamrul-Hasan ABM +6 more
europepmc +1 more source
Not only gut feelings: pancreatic hormone, amylin, controls emotionality and sociability, in a sex divergent manner. [PDF]
Byun S +5 more
europepmc +1 more source
Oral Health Implications of GLP-1 Receptor Agonists and Other Incretin-Based Therapies. [PDF]
Bijoch J.
europepmc +1 more source

